NASDAQ : SANA
Sana Biotechnology, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.57 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 769.36M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 44.71M | 44.30M | 64.04M | 73.30M | 67.06M | 50.41M |
| Research & Development | 140.34M | 146.66M | 207.43M | 253.60M | 204.37M | 274.66M |
| Operating Expenses | 185.06M | 190.96M | 271.47M | 326.90M | 271.43M | 325.07M |
| Operating Income | -185.06M | -190.96M | -271.47M | -326.90M | -271.43M | -325.07M |
| Interest & Investment Income | 4.36M | 3.85M | 10.47M | 9.94M | 3.76M | 676.00K |
| Other Non Operating Income (Expenses) | 4.87M | 4.61M | -7.00K | -52.00K | -674.00K | 305.00K |
| EBT Excluding Unusual Items | -175.83M | -182.50M | -261.01M | -317.01M | -268.34M | -324.09M |
| Asset Writedown | -2.30M | -46.91M | -6.39M | -7.01M | -4.50M | |
| Other Unusual Items | -33.69M | -14.75M | 638.00K | 40.77M | 3.36M | -31.84M |
| Pretax Income | -211.82M | -244.17M | -266.76M | -283.25M | -269.48M | -355.93M |
| Net Income | -211.82M | -244.17M | -266.76M | -283.25M | -269.48M | -355.93M |
| Net Income to Common | -211.82M | -244.17M | -266.76M | -283.25M | -269.48M | -355.93M |
| Shares Outstanding (Basic) | 277.39M | 253.23M | 230.89M | 194.54M | 188.34M | 166.43M |
| Shares Outstanding (Diluted) | 277.39M | 253.23M | 230.89M | 194.54M | 188.34M | 166.43M |
| EPS (Basic) | -0.76 | -0.96 | -1.16 | -1.46 | -1.43 | -2.14 |
| EPS (Diluted) | -0.76 | -0.96 | -1.16 | -1.46 | -1.43 | -2.14 |
| Free Cash Flow | -135.06M | -144.77M | -256.58M | -273.61M | -310.93M | -280.92M |
| Free Cash Flow Per Share | -0.49 | -0.57 | -1.11 | -1.41 | -1.65 | -1.69 |
| EBITDA | -174.19M | -178.21M | -255.97M | -309.36M | -255.80M | -314.00M |
| D&A For EBITDA | 10.87M | 12.75M | 15.50M | 17.54M | 15.62M | 11.07M |
| EBIT | -185.06M | -190.96M | -271.47M | -326.90M | -271.43M | -325.07M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 57.07M | 71.87M | 127.57M | 133.52M | 176.76M | 253.03M |
| Short-Term Investments | 103.42M | 66.51M | 24.93M | 71.68M | 247.20M | 297.97M |
| Cash & Short-Term Investments | 160.49M | 138.38M | 152.50M | 205.19M | 423.96M | 551.00M |
| Prepaid Expenses | 5.94M | 6.10M | 4.48M | 4.49M | 14.37M | 7.11M |
| Restricted Cash | 4.20M | 4.20M | 3.83M | 3.83M | 6.10M | |
| Total Current Assets | 170.63M | 148.68M | 160.81M | 213.51M | 444.44M | 558.10M |
| Property, Plant & Equipment | 60.52M | 65.22M | 135.27M | 145.59M | 159.40M | 161.78M |
| Long-Term Investments | 10.05M | 195.88M | ||||
| Goodwill | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M |
| Other Intangible Assets | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M |
| Other Long-Term Assets | 552.00K | 3.17M | 5.12M | 6.37M | 9.01M | 13.82M |
| Total Assets | 431.52M | 416.89M | 501.02M | 565.30M | 822.72M | 1.13B |
| Accounts Payable | 1.36M | 1.67M | 5.21M | 4.11M | 2.86M | 2.22M |
| Accrued Expenses | 16.67M | 21.52M | 27.69M | 37.98M | 39.12M | 28.91M |
| Current Portion of Leases | 14.91M | 15.34M | 12.53M | 13.20M | 12.39M | 9.16M |
| Other Current Liabilities | 90.81M | 40.20M | 9.20M | 57.13M | 58.95M | |
| Total Current Liabilities | 123.75M | 78.73M | 45.43M | 64.49M | 111.50M | 99.23M |
| Long-Term Leases | 66.03M | 70.92M | 81.66M | 90.90M | 95.86M | 101.78M |
| Other Long-Term Liabilities | 87.17M | 106.36M | 123.42M | 122.41M | 116.04M | 199.89M |
| Total Liabilities | 276.95M | 256.01M | 250.52M | 277.79M | 323.40M | 400.90M |
| Common Stock | 30.00K | 27.00K | 22.00K | 20.00K | 19.00K | 18.00K |
| Additional Paid-In Capital | 2.11B | 2.01B | 1.86B | 1.63B | 1.56B | 1.52B |
| Retained Earnings | -1.96B | -1.85B | -1.60B | -1.34B | -1.05B | -785.36M |
| Comprehensive Income & Other | -66.00K | 28.00K | 14.00K | -60.00K | -4.33M | -1.37M |
| Total Common Equity | 154.57M | 160.88M | 250.50M | 287.51M | 499.31M | 728.50M |
| Shareholders' Equity | 154.57M | 160.88M | 250.50M | 287.51M | 499.31M | 728.50M |
| Total Liabilities & Equity | 431.52M | 416.89M | 501.02M | 565.30M | 822.72M | 1.13B |
| Total Debt | 80.94M | 86.26M | 94.20M | 104.10M | 108.25M | 110.94M |
| Net Cash (Debt) | 79.55M | 52.12M | 58.30M | 101.10M | 325.76M | 635.93M |
| Net Cash Per Share | 0.29 | 0.21 | 0.25 | 0.52 | 1.73 | 3.82 |
| Filing Date Shares Outstanding | 299.36M | 266.87M | 225.02M | 220.45M | 191.35M | 185.18M |
| Total Common Shares Outstanding | 299.31M | 266.73M | 223.92M | 197.86M | 191.02M | 184.93M |
| Working Capital | 46.88M | 69.95M | 115.38M | 149.03M | 332.93M | 458.87M |
| Book Value Per Share | 0.52 | 0.60 | 1.12 | 1.45 | 2.61 | 3.94 |
| Tangible Book Value | -45.25M | -38.94M | 50.68M | 87.68M | 299.49M | 528.68M |
| Tangible Book Value Per Share | -0.15 | -0.15 | 0.23 | 0.44 | 1.57 | 2.86 |
| Machinery | 45.48M | 42.60M | 57.79M | 54.77M | 64.76M | 49.00M |
| Construction In Progress | 40.34M | 26.33M | 1.71M | 1.39M | ||
| Leasehold Improvements | 39.06M | 39.06M | 33.34M | 31.36M | 34.43M | 33.85M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -211.82M | -244.17M | -266.76M | -283.25M | -269.48M | -355.93M |
| Depreciation & Amortization | 10.87M | 12.75M | 15.50M | 17.54M | 15.62M | 11.07M |
| Asset Writedown & Restructuring Costs | 44.61M | 1.89M | 7.01M | |||
| Stock-Based Compensation | 22.82M | 25.46M | 37.68M | 35.53M | 38.34M | 22.36M |
| Other Operating Activities | 47.17M | 27.63M | -10.28M | -49.03M | -82.08M | 61.64M |
| Change in Accounts Payable | -943.00K | -3.54M | 1.38M | 1.03M | 1.06M | -266.00K |
| Change in Other Net Operating Assets | -332.00K | -6.57M | -2.56M | 17.58M | 6.48M | 10.07M |
| Operating Cash Flow | -132.24M | -143.83M | -223.15M | -253.58M | -290.05M | -251.05M |
| Capital Expenditures | -2.82M | -938.00K | -33.43M | -20.03M | -20.88M | -29.86M |
| Sale of Property, Plant & Equipment | 1.07M | 1.43M | ||||
| Investment in Securities | -100.85M | -40.73M | 50.88M | 192.04M | 231.44M | -211.36M |
| Other Investing Activities | -4.57M | |||||
| Investing Cash Flow | -102.60M | -40.24M | 17.45M | 172.01M | 210.56M | -245.80M |
| Long-Term Debt Issued | 7.74M | |||||
| Long-Term Debt Repaid | -347.00K | |||||
| Net Debt Issued (Repaid) | -360.00K | -347.00K | 7.74M | |||
| Issuance of Common Stock | 221.00M | 129.08M | 192.00M | 31.65M | 4.91M | 631.75M |
| Financing Cash Flow | 220.64M | 128.73M | 199.75M | 31.65M | 4.91M | 631.75M |
| Net Cash Flow | -14.20M | -55.33M | -5.95M | -49.92M | -74.58M | 134.90M |
| Free Cash Flow | -135.06M | -144.77M | -256.58M | -273.61M | -310.93M | -280.92M |
| Free Cash Flow Per Share | -0.49 | -0.57 | -1.11 | -1.41 | -1.65 | -1.69 |
| Levered Free Cash Flow | 4.13M | -53.57M | -168.30M | -206.93M | -140.89M | -138.16M |
| Unlevered Free Cash Flow | 4.13M | -53.57M | -168.30M | -206.93M | -140.89M | -138.16M |
| Change in Working Capital | -1.27M | -10.11M | -1.19M | 18.61M | 7.54M | 9.80M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 769.36M | 1.08B | 363.93M | 804.30M | 750.19M | 2.83B |
| Enterprise Value | 689.81M | 1.02B | 261.01M | 632.59M | 350.39M | 2.07B |
| Last Close Price | 2.57 | 4.07 | 1.63 | 4.08 | 3.95 | 15.48 |
| PB Ratio | 4.98 | 6.74 | 1.45 | 2.80 | 1.50 | 3.89 |
| P/TBV Ratio | 7.18 | 9.17 | 2.50 | 5.36 | ||
| Debt / Equity Ratio | 0.52 | 0.54 | 0.38 | 0.36 | 0.22 | 0.15 |
| Net Debt / Equity Ratio | -0.52 | -0.32 | -0.23 | -0.35 | -0.65 | -0.87 |
| Net Debt / EBITDA Ratio | 0.46 | 0.29 | 0.23 | 0.33 | 1.27 | 2.02 |
| Net Debt / FCF Ratio | 0.59 | 0.36 | 0.23 | 0.37 | 1.05 | 2.26 |
| Quick Ratio | 1.30 | 1.76 | 3.36 | 3.18 | 3.80 | 5.55 |
| Current Ratio | 1.38 | 1.89 | 3.54 | 3.31 | 3.99 | 5.62 |
| Return on Equity (ROE) | -152.87% | -118.70% | -99.17% | -72.00% | -43.90% | -61.36% |
| Return on Assets (ROA) | -29.16% | -26.00% | -31.82% | -29.44% | -17.38% | -21.85% |
| Return on Capital Employed (ROCE) | -60.10% | -56.50% | -59.60% | -65.30% | -38.20% | -31.60% |
| Earnings Yield | -29.71% | -22.52% | -73.30% | -35.22% | -35.92% | -12.56% |
| FCF Yield | -17.56% | -13.35% | -70.50% | -34.02% | -41.45% | -9.91% |
| Buyback Yield / Dilution | -17.07% | -9.68% | -18.68% | -3.29% | -13.16% | -1,178.88% |